ArticleScientific data2026
Complete genome sequence of Sphingomonas sp. gentR, a high-level gentamicin-resistant bacterium.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present the complete genome sequence of Sphingomonas sp. gentR, a strain exhibiting high-level resistance to gentamicin (MIC = 40 mg/mL). The genome was assembled from hybrid Illumina and Nanopore sequencing data into a gap-free sequence of 4.0 Mbp, comprising one chromosome and two plasmids. A total of 3,692 coding sequences were predicted, with comprehensive functional annotation revealing genes associated with antibiotic resistance, stress adaptation, and metabolic diversity. Three confirmed resistance genes-ANT(2″)-Ia, ANT(3″)-IIa, and Sul1-were co-localized within a genomic island on plasmid B. This dataset provides insight into the genetic basis of high-level aminoglycoside resistance in Sphingomonas and serves as a valuable resource for studying horizontal gene transfer, environmental adaptation, and bioremediation potential. The genome sequence is publicly available under GenBank accessions CP144670-CP144672 and China National Genomics Data Center (accession number GWHDOHA00000000).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.